Eli Reshef, MD

The Website of Eli Reshef, MD

  • Home
  • About
    • Dr. Reshef’s Bio
    • Why Choose Reshef?
  • FAQ
  • Educate Me!
    • Ectopic Pregnancy
    • Endometriosis
    • Egg Donation
    • Fibroids
    • Infertility
    • Insemination (Artificial)
    • In Vitro Fertilization
      • The IVF Journey
    • Male Factor Infertility
    • Menopause
    • Menstrual Disorders
    • Polycystic Ovarian Syndrome (POCS)
    • Recurrent Pregnancy Losses
    • Unexplained Infertility
  • Contact
    • Directions
  • Links
You are here: Home / Science and Research / Court ruling lifts age limit on morning-after pill

Court ruling lifts age limit on morning-after pill

April 9, 2013 By Eli Reshef

By Monte Morin and Geoffrey Mohan, Los Angeles Times April 5, 2013

President Obama once fretted about the prospect that girls as young as 10 or 11 could walk into a drugstore and buy emergency contraception pills as easily as “bubble gum or batteries.”

With his blessing, the Department of Health and Human Services set aside the advice of medical experts and blocked efforts to allow girls younger than 17 to get the so-called morning-after pill without a prescription.

That age limit is poised to disappear now that a federal judge has cleared the way Friday for girls — and boys — of any age to purchase the medication without having to notify their parents or a doctor.

In a sharply worded ruling that called government regulators “politically motivated and scientifically unjustified,” U.S. District Judge Edward Korman ruled that levonorgestrel-based contraceptives such as Plan B One-Step and Next Choice One Dose should be available over the counter to all customers within 30 days.

“There is no serious health risk associated with use of Plan B as prescribed and intended, much less one that would make restrictions on distribution necessary for its safe use,” Korman wrote.

Unless successfully appealed by the U.S. Department of Justice, the ruling would make contraceptives as readily available to minors as Tylenol or Benadryl. The biggest barrier to access would be the pill’s hefty $50 price tag.

Reproductive rights advocates hailed Korman’s ruling as a victory of science over politics, and said the ruling was a long time in coming for the politically sensitive drug.

“A federal judge has accomplished what two administrations failed to do: make a decision about access to a drug based on medical evidence,” said Michael Halpern, program manager at the Center for Science and Democracy at the Union of Concerned Scientists.

The lawsuit that prompted the order was brought by the Center for Reproductive Rights. On Friday, the center’s president, Nancy Northup, released a statement calling the decision a blow to deep-seated discrimination.

“Women all over the country will no longer face arbitrary delays and barriers just to get emergency contraception,” she said.

Though the ruling noted that both the George W. Bush and Obama administrations had a hand in restricting access, Korman’s action placed reproductive rights groups in the odd position of siding with a Republican-appointed federal judge who had harshly critical words for a Democratic administration.

“This case is not about the potential misuse of Plan B by 11-year-olds,” the judge wrote. “These emergency contraceptives would be among the safest drugs sold over-the-counter,” he noted, and “the number of 11-year-olds using these drugs is likely to be minuscule.”

Justice Department spokeswoman Allison Price said the government was “reviewing the appellate options and expects to act promptly.”

Plan B was the first emergency contraceptive drug approved in the United States and required a prescription when it came on the market in 1999.

The drug, a synthetic hormone, prevents pregnancy by blocking ovulation and impeding the mobility of sperm. It does not cause an abortion in women who are already pregnant; nor does it harm a developing fetus.

In 2006, the Food and Drug Administration allowed adults to buy the drug over the counter but still required prescriptions for those younger than 18.

In late 2011, the FDA was ready to permit the nonprescription sale of the drug to people of all ages, but Health and Human Services Secretary Kathleen Sebelius overruled the agency and continued to require prescriptions for those 16 and younger. She cited concern that the drug had not been tested in girls as young as 11, even though 10% of them are “physically capable of bearing children.”

It was the first time that a Health and Human Services secretary had overruled an FDA decision.

To critics, it seemed that presidential politics was the real reason for Sebelius’ action. The 2012 election was less than a year away.

The Center for Reproductive Rights went to court and argued that the age and prescription requirements limited access to the drug for all women by creating confusion among pharmacists and clerks. Also, because pharmacists kept the drug behind the counter, it was not available outside regular 9-to-5 pharmacy hours.

http://www.latimes.com/news/science/la-sci-plan-b-20130406,0,5624429.story

Related

  • Email
  • Facebook
  • YouTube

Meet Dr. Eli Reshef

The other day, another physician asked me if I had to start all over again, would I still become a physician and would I still choose Reproductive Endocrinology and Infertility as my sub-specialty. I answered with a resounding “yes”. I feel very fortunate to get up every morning looking forward to going to work. I feel privileged to have the opportunity to help people every day, that is every day, including weekends and holidays. Read More About Me Here-

Dr. Reshef's Most Popular Posts

  • Latest
  • Popular
  • Point of View: Big downside to premature return to “normal”
  • Thousands of eggs, embryos possibly damaged at Ohio hospital
  • YOUR EMBRYOS ARE SAFE!
  • Employers Who Wish to Retain Staff Should Consider Having Infertility Benefit
  • Older Men’s Sperm: Worse for the Wear?
  • Today Week Month All
  • OKC Doctor: Planned Parenthood defunding would curtail reproductive care options
  • There is no "baby deadline" test!
  • What You Really Need to Know About Egg Freezing
  • Vitamin D Deficiency- Is There Really a Pandemic?
  • Older Men’s Sperm: Worse for the Wear?
Ajax spinner

Post Archive

  • May 2020
  • March 2018
  • October 2017
  • August 2017
  • March 2017
  • February 2017
  • January 2017
  • February 2016
  • January 2016
  • December 2015
  • October 2015
  • August 2015
  • July 2015
  • May 2015
  • April 2015
  • February 2015
  • December 2014
  • November 2014
  • October 2014
  • September 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014
  • February 2014
  • December 2013
  • November 2013
  • October 2013
  • August 2013
  • July 2013
  • June 2013
  • May 2013
  • April 2013
  • March 2013
  • February 2013
  • January 2013
  • December 2012
  • November 2012
  • October 2012
  • September 2012
  • August 2012

Contact Dr. Eli Reshef

  • We love people, not bots. Please select "Yes, I am Human" from the drop down below.

Recent Posts

  • Point of View: Big downside to premature return to “normal”
  • Thousands of eggs, embryos possibly damaged at Ohio hospital
  • YOUR EMBRYOS ARE SAFE!
  • Employers Who Wish to Retain Staff Should Consider Having Infertility Benefit
  • Older Men’s Sperm: Worse for the Wear?
  • Subfertility May be Harbinger of Disease Later in Life
  • Email
  • Facebook
  • YouTube

Eli Reshef, MD

3433 NW 56th Street, Suite 210-B
Oklahoma CIty , OK 73112
Phone: (405) 945-4701

Post Calendar

March 2021
M T W T F S S
« May    
1234567
891011121314
15161718192021
22232425262728
293031  

Copyright © 2021 · Eli Reshef, MD. All Rights Reserved.